Evidence map›Paper›PMID 40693066›Full record

ArticleCureus2025

Cerebellopontine Angle Epidermoid Cyst With Malignant Transformation Into Squamous Cell Carcinoma: An Unusual Complication of a Benign Intracranial Tumor.

Dianela Gasca Saldaña, Ytel Jazmin Garcilazo Reyes, José Omar Navarro, Daniel Magos Rodríguez, Luis Felipe Arias Ruiz, Maria Lizeth Perez Diaz, Erick Gomez-Apo, Raymundo Hernandez Montes de Oca, Guillermo Axayacalt Gutierrez-Aceves, Ildefonso R De La Peña and 1 more

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Epidermoid cysts of the cerebellopontine angle in pediatric population-an institutional surgical case series and review of literature.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2026
    Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Dianela Gasca SaldañaInternal Medicine, Médica Sur, Mexico City, MEX.
Ytel Jazmin Garcilazo ReyesNeuro-Oncology, Hospital Ángeles del Pedregal, Mexico City, MEX.
José Omar NavarroNeuro-Oncology, Hospital San Angel Inn Universidad, Centro Oncológico Internacional (COI), Mexico City, MEX.
Daniel Magos RodríguezNeuro-Oncology, Hospital San Angel Inn Universidad, Centro Oncológico Internacional (COI), Mexico City, MEX.
Luis Felipe Arias RuizPathology, Médica Sur, Mexico City, MEX.
Maria Lizeth Perez DiazPathology, Médica Sur, Mexico City, MEX.
Erick Gomez-ApoNeuropathology, Hospital General de México, Mexico City, MEX.
Raymundo Hernandez Montes de OcaNeuro-Oncology, Hospital San Angel Inn Universidad, Centro Oncológico Internacional (COI), Mexico City, MEX.
Guillermo Axayacalt Gutierrez-AcevesRadioneurosurgery, Instituto Nacional de Neurologia y Neurocirugia, Mexico City, MEX.
Ildefonso R De La PeñaOncology, Médica Sur, Mexico City, MEX.
Andrés Vega-RosasPain Management Center, Hospital Angeles Mocel, Mexico City, MEX.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epidermoid cysts (ECs) are typically located in the posterior cranial fossa, most commonly at the cerebellopontine angle (CPA). Although generally benign, the cyst's epithelial lining can undergo malignant transformation into squamous cell carcinoma (SCC), a rare occurrence associated with poor prognosis. We present the case of a 55-year-old woman with a history of migraines who was incidentally diagnosed with a right CPA lesion consistent with an EC at the age of 30. Twenty-five years later, she developed progressive right-sided hearing loss, tinnitus, vertigo, headache, dysgeusia, and gait disturbances. Histopathological examination confirmed malignant transformation of the EC into SCC, supported by immunohistochemical markers including p63, p40, CK5/6, and D2-40. She was treated with fractionated stereotactic radiotherapy, carboplatin-paclitaxel chemotherapy, and the immune checkpoint inhibitor pembrolizumab, demonstrating good treatment tolerance and clinical stability.

Indexed as

benign lesionepidermoid cystintracranial tumormalignant transformationsquamous cell carcinoma

Identifiers

PMID40693066
PMCPMC12277640

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.